ArchivesJohn Walker2023-02-27T20:11:47-08:00

Archives

2002, 2025

Prometheus Laboratories Unveils New Data on Precision-Guided Care for IBD at ECCO’25 Congress

Chrystal Johnson2025-02-20T05:27:14-08:002025-02-20|

News & Events Prometheus [...]

2005, 2024

Prometheus Laboratories Presents Data Demonstrating Clinical Validity, Utility, and Positive Economic Impact of Precision-Guided Care at DDW® 2024

John Walker2024-05-20T07:50:41-07:002024-05-20|

News & Events Prometheus [...]

905, 2024

Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services

Judy Gohndrone2024-05-09T10:00:08-07:002024-05-09|

News & Events Prometheus [...]

2112, 2023

Prometheus Laboratories Announces a Major Milestone in Demonstrating Clinical Utility of Precision-Guided Dosing for Optimizing IBD Patient Care and Cost Savings

John Walker2023-12-21T06:05:00-08:002023-12-21|

News & Events Prometheus [...]

2908, 2023

Prometheus Laboratories Surpasses 35 Million Covered Lives Under Positive Medical Policy for Anser® Therapeutic Drug Monitoring

John Walker2024-03-13T11:47:03-07:002023-08-29|

News & Events Prometheus [...]

108, 2023

Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser® Testing

John Walker2024-03-13T11:46:12-07:002023-08-01|

News & Events Prometheus [...]

Previous 123 Next